VSM appears to be a valid method of screening for MCI in an older adult population though it cannot be used for MCI subtype assessment. VSM's concurrent validity is supported by the large number of correlations between the VSM and established tests. It is considered a robust test on its own as the inclusion of other tests failed to improve its CCR significantly.

Smart and sustainable cities are expected to form a cornerstone for achieving resource efficiency and sustainability worldwide. In this specific study we introduce a holistic framework for determining a repository of key performance indicators (KPIs) that are able to evaluate both business-as-usual and novel technologies and services related to smart city solutions. The framework includes six steps: (a) Clustering of the technology/service solutions into groups called Transition Tracks; (b) definition of the main groups of stakeholders; (c) definition of KPIs dimensions (or domains); (d) definition of KPIs repository per dimension; (e) definition of the scope of evaluation per KPI; and (f) threshold definition per KPI. The implementation of the proposed framework led to the development of a repository of 75 KPIs categorized in six dimensions (technical, environmental, economic, social, ICT and legal KPIs) with the corresponding levels of assessment and stakeholders’ group of interest. The proposed repository can serve as a great basis for similar projects to monitor and evaluate the performance of their solutions. Tips and guidance based on the actual implementation and lessons learned from a smart city project are provided.

The wave of digital health is continuously growing and promises to transform healthcare and optimize the patients' experience. Asthma is in the center of these digital developments, as it is a chronic disease that requires the continuous attention of both health care professionals and patients themselves. The accurate and timely assessment of the state of asthma is the fundamental basis of digital health approaches and is also the most significant factor toward the preventive and efficient management of the disease. Furthermore, the necessity of inhaled medication offers a basic platform upon which modern technologies can be integrated, namely the inhaler device itself. Inhaler-based monitoring devices were introduced in the beginning of the 1980s and have been evolving but mainly for the assessment of medication adherence. As technology progresses and novel sensing components are becoming available, the enhancement of inhalers with a wider range of monitoring capabilities holds the promise to further support and optimize asthma self-management. The current article aims to take a step for the mapping of this territory and start the discussion among healthcare professionals and engineers for the identification and the development of technologies that can offer personalized asthma self-management with clinical significance. In this direction, a technical review of inhaler based monitoring devices is presented, together with an overview of their use in clinical research. The aggregated results are then summarized and discussed for the identification of key drivers that can lead the future of inhalers.